Vasopressin and Steroids as Adjunctive Treatment for In-Hospital Cardiac Arrest

Cardiopulmonary arrest occurs in approximately 290 000 hospitalized patients annually in the United States, representing nearly 1% of all admissions and with survival estimated at 20%. To date, most research on cardiopulmonary arrest has focused on patients who experience cardiac arrest in the out-o...

Full description

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 2021-10, Vol.326 (16), p.1583-1585
Main Authors: Haukoos, Jason, Douglas, Ivor S, Sasson, Comilla
Format: Article
Language:English
Subjects:
Cardiac arrest
Etiology
Health services
Patients
Response time
Steroid hormones
Steroids
Vasopressin
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiopulmonary arrest occurs in approximately 290 000 hospitalized patients annually in the United States, representing nearly 1% of all admissions and with survival estimated at 20%. To date, most research on cardiopulmonary arrest has focused on patients who experience cardiac arrest in the out-of-hospital setting with results extrapolated to those with cardiac arrest in hospitals. However, there are distinct differences in the treatment of patients who experience cardiac arrest in the hospital setting where disease processes, etiologies, and illness severity differ and medical response time is often shorter.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2021.15460